Top Markets
#1 Ontology Ontology +41.01%
#2 Bedrock Bedrock +25.43%
#3 Naoris Protocol Naoris Protocol +21.50%
#4 bitcastle Token bitcastle Token +19.95%
#5 DeFiChain DeFiChain +19.85%
#6 DUSK Network DUSK Network +18.55%
#7 pippin pippin +18.34%
#8 Chrema Coin Chrema Coin +15.50%
#9 Amiko Amiko +14.53%
#10 Irys Irys +13.95%
Coin of the day
Ontology Ontology
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Eli Lilly Eli Lilly

Eli Lilly

LLY
Rangering i aksjer #15
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Aksjekurs
$910.55
Markedsverdi
$860.30B
Endring (1 dag)
0.44%
Endring (1 år)
5.28%
Land
US
Handel Eli Lilly (LLY)

Kategori

Healthcare
P/S-forhold for Eli Lilly (LLY)
P/S-forhold per March 2026 TTM: 14.26
Ifølge Eli Lilly sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 14.26. Ved slutten av 2024 hadde selskapet et P/S-forhold på 15.44.
P/S-historikk for Eli Lilly fra 2000 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 14.26 -3.73%
2025 14.81 -4.08%
2024 15.44 0.47%
2023 15.36 26.14%
2022 12.18 30.93%
2021 9.30 41.33%
2020 6.58 16.73%
2019 5.64 1.90%
2018 5.53 24.39%
2017 4.45 16.60%
2016 3.82 -18.23%
2015 4.67 19.45%
2014 3.91 58.51%
2013 2.46 -1.49%
2012 2.50 31.23%
2011 1.91 13.53%
2010 1.68 -6.52%
2009 1.80 -16.98%
2008 2.16 -30.75%
2007 3.12 -13.42%
2006 3.61 -14.14%
2005 4.20 -5.31%
2004 4.44 -26.20%
2003 6.01 -2.75%
2002 6.18 -15.65%
2001 7.33 -20.80%
2000 9.26 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
4.96 -65.20%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.18 -56.66%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
6.35 -55.45%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
5.18 -63.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.40 -69.16%
US